Gene Symbol | SPARC |
Entrez ID | 6678 |
Uniprot ID | P09486 |
Description | secreted protein, acidic, cysteine-rich (osteonectin) |
Chromosomal Location | chr5: 151,661,096-151,687,165 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0001503 |
ossification |
The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance. |
IEA |
BP |
GO:0001937 |
negative regulation of endothelial cell proliferation |
Any process that stops, prevents, or reduces the rate or extent of endothelial cell proliferation. |
IDA |
BP |
GO:0002576 |
platelet degranulation |
The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet. |
TAS |
BP |
GO:0006898 |
receptor-mediated endocytosis |
An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles. |
TAS |
BP |
GO:0007165 |
signal transduction |
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
IEA |
BP |
GO:0007507 |
heart development |
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood. |
IEA |
BP |
GO:0009629 |
response to gravity |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gravitational stimulus. |
IEA |
BP |
GO:0010288 |
response to lead ion |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lead ion stimulus. |
IEA |
BP |
GO:0010595 |
positive regulation of endothelial cell migration |
Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium. |
IDA |
BP |
GO:0016525 |
negative regulation of angiogenesis |
Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis. |
IDA |
BP |
GO:0022604 |
regulation of cell morphogenesis |
Any process that modulates the frequency, rate or extent of cell morphogenesis. Cell morphogenesis is the developmental process in which the shape of a cell is generated and organized. |
IDA |
BP |
GO:0030198 |
extracellular matrix organization |
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix. |
TAS |
BP |
GO:0030324 |
lung development |
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax. |
IEA |
BP |
GO:0032496 |
response to lipopolysaccharide |
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
IEA |
BP |
GO:0033591 |
response to L-ascorbic acid |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an L-ascorbic acid (vitamin C) stimulus. |
IEA |
BP |
GO:0034097 |
response to cytokine |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus. |
IEA |
BP |
GO:0042060 |
wound healing |
The series of events that restore integrity to a damaged tissue, following an injury. |
IEA |
BP |
GO:0043434 |
response to peptide hormone |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals. |
IEA |
BP |
GO:0045471 |
response to ethanol |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus. |
IEA |
BP |
GO:0046686 |
response to cadmium ion |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus. |
IEA |
BP |
GO:0048839 |
inner ear development |
The process whose specific outcome is the progression of the inner ear over time, from its formation to the mature structure. |
IEA |
BP |
GO:0051384 |
response to glucocorticoid |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects. |
IEA |
BP |
GO:0051591 |
response to cAMP |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus. |
IEA |
BP |
GO:0051592 |
response to calcium ion |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus. |
IEA |
BP |
GO:0060348 |
bone development |
The process whose specific outcome is the progression of bone over time, from its formation to the mature structure. Bone is the hard skeletal connective tissue consisting of both mineral and cellular components. |
IEA |
BP |
GO:0071363 |
cellular response to growth factor stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus. |
IEA |
CC |
GO:0005576 |
extracellular region |
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
NAS|TAS |
CC |
GO:0005604 |
basement membrane |
A thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers. |
IEA |
CC |
GO:0005615 |
extracellular space |
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
IBA |
CC |
GO:0005737 |
cytoplasm |
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
IDA |
CC |
GO:0009986 |
cell surface |
The external part of the cell wall and/or plasma membrane. |
IDA |
CC |
GO:0016363 |
nuclear matrix |
The dense fibrillar network lying on the inner side of the nuclear membrane. |
IDA |
CC |
GO:0031091 |
platelet alpha granule |
A secretory organelle found in blood platelets, which is unique in that it exhibits further compartmentalization and acquires its protein content via two distinct mechanisms: (1) biosynthesis predominantly at the megakaryocyte (MK) level (with some vestigial platelet synthesis) (e.g. platelet factor 4) and (2) endocytosis and pinocytosis at both the MK and circulating platelet levels (e.g. fibrinogen (Fg) and IgG). |
IDA |
CC |
GO:0031092 |
platelet alpha granule membrane |
The lipid bilayer surrounding the platelet alpha granule. |
IDA |
CC |
GO:0031093 |
platelet alpha granule lumen |
The volume enclosed by the membrane of the platelet alpha granule. |
TAS |
CC |
GO:0071682 |
endocytic vesicle lumen |
The volume enclosed by the membrane of an endocytic vesicle. |
TAS |
MF |
GO:0005509 |
calcium ion binding |
Interacting selectively and non-covalently with calcium ions (Ca2+). |
IDA |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
MF |
GO:0005518 |
collagen binding |
Interacting selectively and non-covalently with collagen, a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%). |
IDA |
MF |
GO:0050840 |
extracellular matrix binding |
Interacting selectively and non-covalently with a component of the extracellular matrix. |
IBA |
Domain ID | Description |
---|---|
IPR001999 |
Osteonectin-like, conserved site |
IPR002350 |
Kazal domain |
IPR003645 |
Follistatin-like, N-terminal |
IPR011992 |
EF-hand domain pair |
IPR015369 |
Follistatin/Osteonectin EGF domain |
IPR018247 |
EF-Hand 1, calcium-binding site |
IPR019577 |
SPARC/Testican, calcium-binding domain |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
WP3967 |
miR-509-3p alteration of YAP1/ECM axis |
WikiPathways |
WP615 |
Senescence and Autophagy in Cancer |
WikiPathways |
UMLS CUI | UMLS Term |
---|---|
C0009375 |
Colonic Neoplasms |
C0009404 |
Colorectal Neoplasms |
C0019158 |
Hepatitis |
C0020429 |
Hyperalgesia |
C0022658 |
Kidney Diseases |
C0023467 |
Leukemia, Myelocytic, Acute |
C0023890 |
Liver Cirrhosis |
C0023893 |
Liver Cirrhosis, Experimental |
C0024031 |
Low Back Pain |
C0026764 |
Multiple Myeloma |
C0027540 |
Necrosis |
C0027659 |
Neoplasms, Experimental |
C0029434 |
Osteogenesis Imperfecta |
C0041948 |
Uremia |
C0043094 |
Weight Gain |
C0151744 |
Myocardial Ischemia |
C0158266 |
Intervertebral Disc Degeneration |
C0206686 |
Adrenocortical Carcinoma |
C0919267 |
Ovarian Neoplasm |
Tissue | Cell Type |
---|---|
adrenal gland |
glandular cells |
cerebral cortex |
neuropil |
kidney |
cells in glomeruli |
placenta |
decidual cells |
placenta |
trophoblastic cells |
skin |
fibroblasts |
testis |
cells in seminiferous ducts |
testis |
Leydig cells |
Pubmed ID | Author | Year | Title |
---|---|---|---|
15291743 |
Diao et al. |
2004 |
The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray |
22951915 |
Haozi et al. |
2012 |
Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome |
23824412 |
Piltonen et al. |
2013 |
Mesenchymal Stem/Progenitors and Other Endometrial Cell Types From Women With Polycystic Ovary Syndrome (PCOS) Display Inflammatory and Oncogenic Potential |
25393639 |
Ambekar et al. |
2014 |
Proteomics of follicular fluid from women with polycystic ovary syndrome suggests molecular defects in follicular development |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
COL1A2 |
1278 |
P08123 |
0.52 |
COL13A1 |
1305 |
Q5TAT6 |
0.52 |
FN1 |
2335 |
P02751 |
0.52 |
PDGFA |
5154 |
P04085 |
0.52 |
SDC2 |
6383 |
P34741 |
0.52 |
COL2A1 |
1280 |
P02458 |
0.62 |
HSPG2 |
3339 |
P98160 |
0.62 |
PLAT |
5327 |
P00750 |
0.62 |
XRCC6 |
2547 |
P12956 |
0.63 |
SPARC |
6678 |
P09486 |
0.63 |
ZNF579 |
163033 |
Q8NAF0 |
0.63 |
PDGFB |
5155 |
P01127 |
0.75 |
PLG |
5340 |
P00747 |
0.85 |
COL1A1 |
1277 |
P02452 |
0.86 |
COL3A1 |
1281 |
P02461 |
0.90 |
CTSK |
1513 |
P43235 |
0.52 |
THBS1 |
7057 |
P07996 |
0.52 |
TGM2 |
7052 |
P21980 |
0.62 |
RASSF7 |
8045 |
Q02833 |
0.63 |
PDLIM5 |
10611 |
Q96HC4 |
0.63 |
UBQLN1 |
29979 |
Q9UMX0 |
0.63 |
TGFB1 |
7040 |
P01137 |
0.65 |
VEGFA |
7422 |
P15692 |
0.65 |
COL5A1 |
1289 |
P20908 |
0.75 |